We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Maker Hit With Stock Drop Suit Over Fibrotic Disease Treatment Drug

(March 15, 2019, 10:39 AM EDT) -- BOSTON — An investor filed a securities class action lawsuit against a pharmaceutical company and two of its senior officers on March 12, alleging that the defendants misrepresented the clinical trial...
To view the full article, register now.